Pause on NICE’s cost recovery plans
Plans for NICE to recover the costs of its appraisals of drugs, medical devices and diagnostics, through charges to the companies which make them, have been put on hold until the Government completes its life sciences strategy.
Latest news headlines
Care home residents should be helped to brush their teeth twice a day, says NICE
06 January 2017
NICE says liver cancer treatment to stay within the Cancer Drugs Fund, but not recommended for routine NHS use.
The drug, sorafenib (also known as Nexavar), which is used for treating advanced hepatocellular carcinoma, is not value for money, NICE has said in new draft guidance.
30 December 2016
At this time of year we like to stop and reflect on some of the news we’ve shared with you over the past twelve months…
Kadcyla (also called trastuzumab emtansine and made by Roche) is currently being funded through the Cancer Drugs Fund. NICE is looking again at its 2015 guidance on the drug to see whether it should be funded routinely on the NHS.
29 December 2016
NICE has issued draft guidance setting out what medicines adults, young people and children with asthma should take to control symptoms and reduce asthma attacks.
28 December 2016
Due to a technical fault, the December content updates to the NICE BNF and BNFC apps have been delayed until early January 2017.
22 December 2016